Download presentation
1
MS Phoenix WinNonLin Project
Due 9/21/15 Non-compartment analysis (NCA) of simulated oral plasma data Everyone uses drug. Plot and Table
2
Integration of Kinetic and Physiological Concepts
Lecture #12 Integration of Kinetic and Physiological Concepts
3
Clearance vs. V vs. t1/2 Increase V; Increase CL
Decrease t1/2; Increase CL
4
k, t1/2 and AUC Unspoken Assumption: First Order Exponential Decay
Kinetics
5
Future Current: Kinetics IV bolus dose We will
Kinetics Extravascular Dose Constant-Rate Input Multiple-Doses Disease Non-linearities Drug Interactions
6
PK Parameters vs. Physiological Variables
Primary PK Parameters Protein binding, enzyme activity, blood flows and partitioning Dose, V, CL, CLH, CLR, CLINT, dose, fu, blood-to-plasma equilibration ratio, Q, QR, QH Secondary PK Parameters Depend on Primary PK parameters Drug Concentrations, Rate Constants, AUC k = CL/V Observations AUC = Adose/CL CMAX = Adose/V Cu = fu (Adose/V)
7
Hepatic Extraction Ratio (EH)
High EH Clearance cannot exceed hepatic blood flow (QH) Low EH
8
Hepatic Extraction Ratio (Eh)
Enzymatic Activity/Concentration (CLint) Hepatic Blood Flow (Qh) Protein Binding (fu)
9
Low EH (Sensitive to Enzyme Activity)
Inhibitor opioid analgesic drug Inducer Rifpampin (Antibiotic) Troleandomycin (macrolide antibiotic) Cytochrome P450 3A4
10
Low EH (Sensitive to Enzyme Activity)
Inhibited CLint =1 L/hr fu = 1 Hepatic Clearance (CLH) Induced Hepatic Extraction Ratio (EH)
11
Low EH (Insensitive to hepatic blood flow (QH))
CLint =1 L/hr fu = 1 Hepatic Clearance (CLH) Hepatic Extraction Ratio (EH)
12
low EH (Sensitive to Protein Binding)
CLint =1 L/hr Hepatic Clearance (CLH) Hepatic Extraction Ratio (EH)
13
low EH (Sensitive to k and t1/2)
CLint =1 L/hr Elim. Rate Constant (k) Half time (t1/2)
14
high EH (Insensitive to Enzyme Activity)
Heart Drug P450 Inducer Pentobarbital is a sedative. Pentobarbital Inhibitors? Cytochrome P450 (P450)
15
high EH (Insensitive to Enzyme Activity)
Low Inhibition Recall: P450 Inhibitor P450 Inhibitor Cytochrome P450 3A4 inhibitor P450 = Cytochrome P450 synthetic opioid analgesic
16
high EH (Insensitive to Enzyme Activity)
High Inhibition P450 inhibitor P450 = Cytochrome P450 synthetic opioid analgesic
17
High EH (Insensitive to Enzyme Activity)
Induced Inhibited CLint =1000 L/hr fu = 1 Hepatic Clearance (CLH) Hepatic Extraction Ratio (EH) Induced Inhibited
18
high EH (Sensitive to Blood Flow)
Reduce QH Local Anesthetic Anti-hypertensive Anti-hypertensive
19
high EH (Sensitive to Blood Flow)
CLint =1000 L/hr fu = 1 Hepatic Clearance (CLH) Hepatic Extraction Ratio (EH)
20
high EH (Insensitive to Protein Binding)
CLint =1000 L/hr Hepatic Clearance (CLH) Hepatic Extraction Ratio (EH)
21
high EH (Insensitive to k and t1/2)
CLint =1000 L/hr Elim. Rate Constant (k) Half time (t1/2)
22
Hepatic Clearance (CLh) Summary
Low Eh Sensitive to enzyme activity/concentration (CLint) Insensitive to hepatic blood flow (Qh) Sensitive to protein binding (fu) Sensitive to k and t1/2 High Eh Insensitive to enzyme activity/concentration (CLint) Sensitive to hepatic blood flow (Qh) Insensitive to protein binding (fu) Insensitive to k and t1/2
23
a b a b
24
Excretion Rate
25
fu vs. Renal Excretion Rate
Total Filtration Rate Secretion Filtration Rate Glomerulus Filtration Rate
26
fu vs. “Renal Excretion Rate”
Excretion Rate in units of clearance (volume/hour) diuretic
27
Total Secretion Filtration Excretion Rate in L/hr units Excretion Rate in mg/hr units
28
Renal Extraction Ratio (ER)
29
Constant ER Renal Extraction Ratio Excretion Rate Total Excretion Rate
Filtration Rate Secretion Rate
30
Constant EH
31
Relationships
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.